Chromatin Bioscience Signs Collaboration Agreement with Astellas
EDINBURGH, Scotland, April 14, 2025 /PRNewswire/ -- Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with Astellas Pharma, a global life sciences company. Under the agreement, Chromatin Bioscience will use its proprietary chromatinLENS platform to design cell-selective synthetic promoters aligned...
CARsgen’s CAR-T Product Zevor-Cel Included in China’s Commercial Health Insurance Innovative Drug Catalogue
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced today announced with great pleasure that its independently developed fully human BCMA-targeted CAR-T product, zevorcabtagene autoleucel (zevor-cel, R&D code: CT053), has been included in China's Commercial Health Insurance Innovative...
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the Taiwan Food and Drug Administration for the Treatment of Moderately to Severely Active Ulcerative Colitis
SHANGHAI, Aug. 14, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Application (NDA) for VELSIPITY® (etrasimod) for the treatment of patients with moderately to severely active ulcerative...
BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)
SHANGHAI, Feb. 23, 2025 /PRNewswire/ -- BioCity Biopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist, SC0062, met the 12-week primary endpoint of a reduction in proteinuria in the diabetic kidney disease (DKD) cohort of its randomized, double-blind, placebo-controlled Phase 2 trial (2-SUCCEED). The results of the trial are summarized below: Efficacy: SC0062 significantly reduced proteinuria in the high-dose group...
SayHeart: The AI Powerhouse Decoding Health Complexity
KUALA LUMPUR, Malaysia and SINGAPORE, July 20, 2023 /PRNewswire/ -- SayHeart, an inventive start-up, is set to redefine the healthcare industry with its AI-powered technology that simplifies convoluted health data into comprehensible narratives. Employing Generative AI, SayHeart has devised an algorithm that seamlessly translates medical jargon, health reports, and complex imaging into...
FIELD MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA FOR FOCAL PFA IN SCAR-RELATED VT AT HEART RHYTHM 2025
Eight presentations, including late-breaking science, live cases, and a landmark symposium CARDIFF-BY-THE-SEA, Calif., April 23, 2025 /PRNewswire/ -- Field Medical Inc., a leader in cardiac pulsed field ablation (PFA) technology, announced today its FieldForce™ Ablation System will be featured in eight scientific presentations at the 46th annual Heart Rhythm Society (HRS)...
On Gautam Adani’s 60th birthday, the Adani Family commits Rs 60,000 Cr to charity
Donation to be utilized in healthcare, education, and skill development AHMEDABAD, India, June 24, 2022 /PRNewswire/ -- On the year of the centenary birth anniversary of Gautam Adani's father Shri Shantilal Adani, and Gautam Adani's own 60th birthday, the Adani Family has committed a donation of Rs 60,000 crore to a range...
Oral Care Brand Bitvae Receives American Dental Association Certificate for its D2 and S2 Smart Electric Toothbrushes
The brand's connected technology and intuitive product features help its users monitor and improve their oral care routine and that of their families. NEW YORK, Nov. 22, 2022 /PRNewswire/ -- Bitvae, a brand dedicated to making its customers' oral care routine easy and enjoyable with high-performance products, is pleased to announce that it has received the American Dental Association (ADA)...
Smartee and Dental Monitoring Partner to Simplify Refinement Workflows for Orthodontists
SHANGHAI, Sept. 5, 2025 /PRNewswire/ -- Smartee Denti-Technology, a leading innovator in clear aligner solutions, and Dental Monitoring, the global leader in AI-powered remote monitoring for orthodontics, today announced a new integration designed to simplify and accelerate refinement workflows for orthodontists and dental professionals. Get DM SmartSTL from Smartee Denti-Technology Traditionally, refinement in clear aligner treatment requires...
Marlabs welcomes Arun Mukunda as Chief Revenue Officer
Accelerates focus on Data, AI, and Digital Product Engineering (DPE) in Lifesciences, Banking, and Healthcare PISCATAWAY, N.J. and BANGALORE, India, April 30, 2024 /PRNewswire/ -- In keeping with its growth plans, the global digital solutions company Marlabs LLC today announced the appointment of Arun Mukunda as its Chief Revenue Officer...
